-
After a positive coronary ct scan, patients often undergo stress myocardial perfusion scanning, but the relationship between these two tests in relation to prognosis is poorly understood.
-
Kleemann and his colleagues from Ludwigshafen, Germany, report on survival of transvenous defibrillation leads during long-term follow-up.
-
Mild muscle symptoms occasionally prevent some patients from taking statin drugs.
-
-
The value of revascularization before major vascular surgery in patients with stress induced myocardial ischemia has not been tested.
-
Although Mitral Annular Calcium (MAC) is a risk for stroke, the mechanism is unclear. MAC is associated with complex proximal aorta (before the left subclavian) aorta atheromatous plaques and is seen in patients with risk factors for atherosclerosis.
-
GlaxoSmithKline's rosiglitazone (Avandia) will receive a black box warning by the FDA because of concerns over heart failure associated with use of the drug.
-
Rosuvastatin and atorvastatin at their maximal doses, favorably change HDL subpopulation levels, but rosuvastatin is significantly more potent than atorvastatin for this purpose
-
Rosuvastatin plus ezetimibe may improve the management of high-risk patients by increasing the number that reach goal LDL cholesterol levels.
-
Women harbor less atherosclerotic plaque within their coronary arteries, despite the greater prevalence of atherogenic risk factors.
